Superdrolyn 10 mg Driada Medical

Description

Superdrolyn 10 mg Driada Medical — methasterone from Driada Medical at 10 mg. 17α-methylated masteron analog with dramatic potency. Hard, dry gains; very hepatotoxic. 3–4 week maximum cycle with full liver support.

Key Benefits

• Superdrol — one of the most potent oral anabolics ever commercialised
• Rapid strength and lean mass in 2–4 weeks
• Does not aromatise — zero water, zero bloat
• Extreme hepatotoxicity — short cycles mandatory
• Not for beginners, not for back-to-back runs
• Each unit dosed at 10 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 10–30 mg/day for 2–4 weeks. Most users see full effect at 10–20 mg. Above 30 mg/day liver enzymes spike severely. Cycles over 4 weeks are inadvisable.

How It Works

17α-methyl 2α,17β-dimethyl DHT-derivative. Potent AR agonist with zero aromatisation and zero progestagenic activity — pure lean-mass accrual. Extreme strength gains in first week. Lipid-profile devastation within 2 weeks.

Pharmacokinetics

Plasma half-life approximately 8 hours. Split daily dose 2–3×. Among the MOST hepatotoxic orals in commercial use. ALT/AST at week 2 and week 4 non-negotiable. Aggressive liver support (TUDCA 500 mg/day + NAC 1200 mg/day) from day 1.

Potential Side Effects

Liver burden extreme — well beyond methandienone at equivalent doses. HDL collapses. LDL climbs. Back pumps and lethargy common. Mood volatility. Requires 8+ weeks off between cycles minimum; some researchers recommend never running twice in a year.

Cycle & Stacking Guide

Short mass-cycle kickstart: 10–20 mg/day weeks 1–3 or 1–4 alongside a testosterone base (test E 500 mg/week). Drop superdrol at week 4, continue the injectable. Full liver panel before, during (week 2), and 4 weeks post-cycle.

Manufacturer Notes

Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.